Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001763270 | SCV001990663 | uncertain significance | not provided | 2019-03-26 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002540335 | SCV003264628 | likely benign | Spastic paraplegia | 2022-05-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004988725 | SCV005612955 | uncertain significance | Inborn genetic diseases | 2024-08-02 | criteria provided, single submitter | clinical testing | The c.3088C>T (p.R1030W) alteration is located in exon 20 (coding exon 20) of the KDM5C gene. This alteration results from a C to T substitution at nucleotide position 3088, causing the arginine (R) at amino acid position 1030 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |